Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074705 · ClinicalTrials.gov registry record · Phase 1
A Study of DS-1471a In Subjects With Advanced Solid Tumors
A Phase 1 study, sponsored by Daiichi Sankyo Co..
- Terminated
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT06074705: Clinical Trial Phase 1 study, sponsored by Daiichi Sankyo Co..
NCT06074705 is a Phase 1 study that was terminated before completion, run by Daiichi Sankyo Co.. The registered enrollment target is 17 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06074705, a Phase 1 study, was terminated before completion, sponsored by Daiichi Sankyo Co..
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
This first-in-human (FIH) study will assess the safety, preliminary efficacy, pharmacokinetics (PK), and immunogenicity of DS-1471a in participants with advanced or metastatic solid tumors.
Interventions
- DRUG DS-1471a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2025-07-29 |
| Phase | Phase 1 |
Why NCT06074705 stopped before completion
NCT06074705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 1 intervention - of which DS-1471a is the first listed.
NCT06074705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06074705 about?
NCT06074705 is a clinical study titled "A Study of DS-1471a In Subjects With Advanced Solid Tumors". This first-in-human (FIH) study will assess the safety, preliminary efficacy, pharmacokinetics (PK), and immunogenicity of DS-1471a in participants with advanced or metastatic solid tumors.
What is the current status of trial NCT06074705?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2023-08-04. Estimated completion is 2025-07-29.
What interventions are being tested in trial NCT06074705?
The interventions under investigation include: DS-1471a (DRUG).
Who is sponsoring clinical trial NCT06074705?
This trial is sponsored by Daiichi Sankyo Co., which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06074705's enrollment target sits among peer trials
17 1785th of 2000 higher than 215 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI